Navigation Links
Varian Medical Systems Signs Collaboration Agreement to Bring Advanced Radiotherapy Equipment to Indonesia
Date:9/12/2008

JAKARTA, Indonesia, Sept. 12 /PRNewswire-FirstCall/ -- Cancer patients in Indonesia will gain access to advanced radiotherapy treatments following the signing of a Memorandum of Understanding (MOU) today between Varian Medical Systems (NYSE: VAR) and Indonesia's first private cancer hospital. Under the MOU, Siloam Hospitals and Varian have agreed to pursue a collaborative relationship to explore opportunities for developing innovative health solutions for delivering world class cancer treatment in Indonesia.

Today's signing ceremony is being carried out by Tim Guertin, CEO of Varian Medical Systems and DR. Mochtar Riady, founder of the Lippo Group, watched by John Heffern, Deputy Chief of Mission at the US Embassy, Dr. Gershu Paul, CEO of Siloam Hospitals and Professor Susan Tai, president of the Mochtar Riady Institute for Nanotechnology.

DR. Riady said, "It is wonderful for the Mochtar Riady Comprehensive Cancer Centre to partner with Varian Medical Systems, which is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. We are very enthusiastic about working with Varian to bring such leading technologies and therapies to Indonesia in our fight against cancer."

The "Building of Hope", which incorporates the MRCCC, is a new 29-story, 210-bed specialist hospital in central Jakarta. One of the top ten tallest hospitals in the world, it is expected to be a major center of excellence for cancer in the Southeast Asia region when operational in December 2009.

"This splendid new facility will be a landmark center and will provide Indonesia cancer patients with much-needed access to the latest and most effective forms of radiotherapy treatment," said Tim Guertin, president and chief executive officer of Varian Medical Systems. "Varian is delighted to be working with Siloam Hospitals Group to make this very significant project a reality."

The MRCCC, which plans to acquire two Clinac(R) iX linear accelerators equipped with the country's first On-Board Imager(R) devices that enable targeted image-guided radiotherapy (IGRT), will be the most fully equipped cancer centre in Indonesia. IGRT is an extremely precise form of treatment that utilizes multiple imaging and motion management techniques to target tumors precisely and avoid damaging surrounding healthy tissue. DR. Riady said, "The vision for the MRCCC is to provide an international standard private cancer and specialist hospital in Central Jakarta, using state of the art equipment that incorporates the latest generation of smart IT systems."

Nearly 800,000 people in Indonesia are afflicted with cancer each year but advanced cancer facilities are rare in the country.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

Siloam Hospitals Group contact: Andrew Mills, + 62 (0) 811 866 477

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

About Siloam Hospitals Group:

Siloam Hospitals Group is a division of PT Lippo Karawaci, Indonesia's largest broad-based property company and, amongst other awards, was winner of Euro Money 2005 Best Property Developer. Siloam Hospitals is Indonesia's premier private hospital group, currently comprising 4 international standard hospitals and one specialist clinic across Jakarta and Surabaya. Siloam Hospitals is investing US$500 million over the next 5~10 years to build 10 new 'green-field' hospitals including Kemang Village, Bandung and Semanggi. The Mochtar Riady Comprehensive Cancer Centre at Semanggi in Central Jakarta will, when completed by the end of 2009, be Indonesia's first private Comprehensive Cancer Centre and will service the needs of thousands of Indonesians, many of whom are now traveling overseas for cancer treatments. Siloam Hospitals Lippo Karawaci (SHLK) is located around 20 km from Jakarta and is the first hospital in Indonesia to attain international hospital accreditation from USA-based Joint Commission International (or JCI). For more information, visit http://www.siloamhospitals.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LOreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008
2. Genetic variants associated with vitamin B12
3. National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Evas Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer
4. APA resolves to play leading role in improving treatment for gender-variant people
5. New ovarian stimulation technique offers more cancer patients the chance to preserve their fertility
6. Varian and Axeda Win M2M Value Chain Award for Service Excellence
7. Ovarian cancers specific scent detected by dogs
8. Gene Variant May Contribute to Alzheimers Disease
9. Symptom Screening Plus a Simple Blood Test Equals a 20 Percent Jump in Early Detection of Ovarian Cancer
10. Symptoms Plus Blood Test Boost Ovarian Cancer Detection
11. Symptom screening plus a simple blood test improves early detection of ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... Five Star Glass is new to the Texas market, but ... of auto glass for most makes and models, in Grand Prairie, TX, located in the ... They have been a family owned business for the past 40 years with 32 convenient ...
(Date:8/22/2017)... ... , ... “Glimpses Of Light”: is a unique and thought inspiring guide ... creation of published author, J.M. Shepherd, a writer, teacher, traveler, and metaphysician, the author ... , Shepherd shares, “Love is one of the least understood and yet most sought-after ...
(Date:8/21/2017)... MO (PRWEB) , ... August 22, 2017 , ... PracticeMatch, ... fairs to help healthcare employers connect with physicians and advanced practitioners like nurse ... virtual career fairs in August through November of this year. The online career ...
(Date:8/21/2017)... ... 2017 , ... SportsEngine, Inc. , a division of ... of North Country Region Volleyball and will power registration, scheduling, and competition results ... sport management software to their member clubs. , SportsEngine provides financial ...
(Date:8/21/2017)... ... , ... PIXACORE , an independent full-service agency with a decade of ... the year by MM&M. , This is the first time PIXACORE has made the ... agency. PIXACORE’s newfound recognition reflects its steady trajectory of growth and recent strategic ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... 2017 Three Tru-D SmartUVC robots have arrived at ... . Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 ... environmental services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at ... "Although the BAACH has a very low ...
(Date:7/27/2017)... 27, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... June 30, 2017.  The Company reported second quarter net ... the prior year period, and an increase of 2.1% ... points of contribution from the LDR Holding Corporation acquisition, ... quarter of 2016, or 0.3% on a constant currency ...
(Date:7/26/2017)... 26, 2017 Sancilio Pharmaceuticals Company, Inc. (SPCI) ... trial evaluating Altemia TM , an oral therapy for ... Cell Disease (SCD). The SCOT Trial, is a double-blind, ... safety of Altemia TM in pediatric patients aged ... IND 125274. "The ...
Breaking Medicine Technology: